These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia. Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Anguenot T; Bernard Y; Bassand JP Am J Hematol; 1995 Sep; 50(1):20-5. PubMed ID: 7668220 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban. Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088 [TBL] [Abstract][Full Text] [Related]
6. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Greinacher A; Michels I; Mueller-Eckhardt C Thromb Haemost; 1992 May; 67(5):545-9. PubMed ID: 1325681 [TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies. Cola C; Ansell J Am Heart J; 1990 Feb; 119(2 Pt 1):368-74. PubMed ID: 1689094 [TBL] [Abstract][Full Text] [Related]
8. [Thrombopenia induced by heparin. From physiopathology to treatment]. Gruel Y Ann Med Interne (Paris); 1997; 148(2):136-41. PubMed ID: 9238438 [TBL] [Abstract][Full Text] [Related]
9. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896 [TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Warkentin TE; Greinacher A Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477 [TBL] [Abstract][Full Text] [Related]
11. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Morris TA; Castrejon S; Devendra G; Gamst AC Chest; 2007 Oct; 132(4):1131-9. PubMed ID: 17646239 [TBL] [Abstract][Full Text] [Related]
13. Recurrent arterial thromboses in a woman with heparin induced thrombocytopenia, successfully managed with iloprost followed by clopidogrel. An alternative therapeutic option for heparin induced thrombocytopenia type II syndrome. Megalopoulos A; Vasiliadis K; Tsachalis T; Tsalis K; Blouhos K; Alexandridou S; Betsis D Int Angiol; 2006 Mar; 25(1):84-9. PubMed ID: 16520730 [TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia. Chong BH Aust N Z J Med; 1992 Apr; 22(2):145-52. PubMed ID: 1530537 [TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Magnani HN Thromb Haemost; 1993 Oct; 70(4):554-61. PubMed ID: 7509508 [TBL] [Abstract][Full Text] [Related]
16. [Heparin-associated thrombocytopenia: successful therapy of patients after prospective selection of a compatible heparinoid with the heparin-induced platelet activation test]. Greinacher A; Michels I; Mueller-Eckhardt C Beitr Infusionsther; 1992; 30():408-12. PubMed ID: 1284747 [TBL] [Abstract][Full Text] [Related]
17. [Hypercoagulation caused by heparin-associated type II thrombocytopenia]. Bux-Gewehr I; Helmling E; Seyfert UT Z Kardiol; 1996 Sep; 85(9):656-60. PubMed ID: 8992808 [TBL] [Abstract][Full Text] [Related]
18. Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. Greinacher A; Michels I; Liebenhoff U; Presek P; Mueller-Eckhardt C Br J Haematol; 1993 Aug; 84(4):711-6. PubMed ID: 8217831 [TBL] [Abstract][Full Text] [Related]